nodes	percent_of_prediction	percent_of_DWPC	metapath
Flutamide—CYP2C19—urine—nephrolithiasis	0.0553	0.142	CbGeAlD
Flutamide—CYP1A2—urine—nephrolithiasis	0.0452	0.116	CbGeAlD
Flutamide—CYP3A4—urine—nephrolithiasis	0.0327	0.0841	CbGeAlD
Flutamide—AHR—nephron tubule—nephrolithiasis	0.0326	0.0838	CbGeAlD
Flutamide—Jaundice cholestatic—Hydrochlorothiazide—nephrolithiasis	0.0309	0.0505	CcSEcCtD
Flutamide—AHR—cortex of kidney—nephrolithiasis	0.0279	0.0717	CbGeAlD
Flutamide—Blood urea increased—Hydrochlorothiazide—nephrolithiasis	0.0256	0.0419	CcSEcCtD
Flutamide—Ecchymosis—Hydrochlorothiazide—nephrolithiasis	0.0245	0.0401	CcSEcCtD
Flutamide—Diabetes mellitus—Hydrochlorothiazide—nephrolithiasis	0.0226	0.037	CcSEcCtD
Flutamide—Haemolytic anaemia—Hydrochlorothiazide—nephrolithiasis	0.0218	0.0357	CcSEcCtD
Flutamide—Libido decreased—Hydrochlorothiazide—nephrolithiasis	0.0212	0.0347	CcSEcCtD
Flutamide—Hot flush—Hydrochlorothiazide—nephrolithiasis	0.0211	0.0344	CcSEcCtD
Flutamide—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.021	0.0343	CcSEcCtD
Flutamide—Menopausal symptoms—Hydrochlorothiazide—nephrolithiasis	0.0209	0.0341	CcSEcCtD
Flutamide—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.0195	0.032	CcSEcCtD
Flutamide—Toxic epidermal necrolysis—Hydrochlorothiazide—nephrolithiasis	0.0177	0.029	CcSEcCtD
Flutamide—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.0177	0.029	CcSEcCtD
Flutamide—CYP1B1—nephron tubule—nephrolithiasis	0.017	0.0436	CbGeAlD
Flutamide—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.0157	0.0256	CcSEcCtD
Flutamide—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.0155	0.0254	CcSEcCtD
Flutamide—CYP1B1—renal system—nephrolithiasis	0.0154	0.0397	CbGeAlD
Flutamide—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.0154	0.0251	CcSEcCtD
Flutamide—CYP1B1—kidney—nephrolithiasis	0.0149	0.0383	CbGeAlD
Flutamide—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.0148	0.0242	CcSEcCtD
Flutamide—AR—renal system—nephrolithiasis	0.0146	0.0376	CbGeAlD
Flutamide—CYP1B1—cortex of kidney—nephrolithiasis	0.0145	0.0373	CbGeAlD
Flutamide—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.0145	0.0237	CcSEcCtD
Flutamide—AR—kidney—nephrolithiasis	0.0141	0.0363	CbGeAlD
Flutamide—AR—cortex of kidney—nephrolithiasis	0.0137	0.0354	CbGeAlD
Flutamide—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.0136	0.0223	CcSEcCtD
Flutamide—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.0134	0.022	CcSEcCtD
Flutamide—Erythema—Hydrochlorothiazide—nephrolithiasis	0.0119	0.0194	CcSEcCtD
Flutamide—CYP3A5—nephron tubule—nephrolithiasis	0.0117	0.0302	CbGeAlD
Flutamide—Tension—Hydrochlorothiazide—nephrolithiasis	0.0116	0.019	CcSEcCtD
Flutamide—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.0115	0.0188	CcSEcCtD
Flutamide—CYP1A2—renal system—nephrolithiasis	0.011	0.0284	CbGeAlD
Flutamide—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.011	0.018	CcSEcCtD
Flutamide—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.011	0.0179	CcSEcCtD
Flutamide—CYP1A1—renal system—nephrolithiasis	0.0109	0.028	CbGeAlD
Flutamide—Malaise—Hydrochlorothiazide—nephrolithiasis	0.0107	0.0175	CcSEcCtD
Flutamide—CYP3A5—renal system—nephrolithiasis	0.0107	0.0274	CbGeAlD
Flutamide—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.0106	0.0174	CcSEcCtD
Flutamide—CYP1A1—kidney—nephrolithiasis	0.0105	0.0271	CbGeAlD
Flutamide—CYP3A5—kidney—nephrolithiasis	0.0103	0.0265	CbGeAlD
Flutamide—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0165	CcSEcCtD
Flutamide—CYP3A5—cortex of kidney—nephrolithiasis	0.01	0.0258	CbGeAlD
Flutamide—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00998	0.0163	CcSEcCtD
Flutamide—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00976	0.016	CcSEcCtD
Flutamide—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00968	0.0158	CcSEcCtD
Flutamide—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00948	0.0155	CcSEcCtD
Flutamide—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00923	0.0151	CcSEcCtD
Flutamide—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00875	0.0143	CcSEcCtD
Flutamide—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.0086	0.0141	CcSEcCtD
Flutamide—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00841	0.0138	CcSEcCtD
Flutamide—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00834	0.0137	CcSEcCtD
Flutamide—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00828	0.0135	CcSEcCtD
Flutamide—CYP3A4—renal system—nephrolithiasis	0.008	0.0206	CbGeAlD
Flutamide—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00798	0.013	CcSEcCtD
Flutamide—CYP3A4—kidney—nephrolithiasis	0.00773	0.0199	CbGeAlD
Flutamide—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00694	0.0114	CcSEcCtD
Flutamide—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00685	0.0112	CcSEcCtD
Flutamide—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00662	0.0108	CcSEcCtD
Flutamide—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.0064	0.0105	CcSEcCtD
Flutamide—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00615	0.0101	CcSEcCtD
Flutamide—Rash—Hydrochlorothiazide—nephrolithiasis	0.0061	0.00998	CcSEcCtD
Flutamide—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.0061	0.00997	CcSEcCtD
Flutamide—Headache—Hydrochlorothiazide—nephrolithiasis	0.00606	0.00992	CcSEcCtD
Flutamide—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00575	0.00941	CcSEcCtD
